Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 16
Encontrada(s) 1 página(s)

Addi. Archivo Digital para la Docencia y la Investigación
Publicación Artículo científico (JournalArticle)

A fluorogenic cyclic peptide for imaging and quantification of drug-induced apoptosis

  • Barth, Nicole D.
  • Subirós Funosas, Ramón
  • Mendive Tapia, Lorena
  • Duffin, Rodger
  • Shields, Mario A.
  • Cartwright, Jennifer A.
  • Troeira Henriques, Sónia
  • Sot Sanz, Jesús
  • Goñi Urcelay, Félix María
  • Lavilla, Rodolfo
  • Marwick, John A.
  • Vermeren, Sonja
  • Rossi, Adriano G.
  • Egeblad, Mikala
  • Dransfield, Ian
  • Vendrell, Marc
Programmed cell death or apoptosis is a central biological process that is dysregulated in many diseases, including inflammatory conditions and cancer. The detection and quantification of apoptotic cells in vivo is hampered by the need for fixatives or washing steps for non-fluorogenic reagents, and by the low levels of free calcium in diseased tissues that restrict the use of annexins. In this manuscript, we report the rational design of a highly stable fluorogenic peptide (termed Apo-15) that selectively stains apoptotic cells in vitro and in vivo in a calcium-independent manner and under wash-free conditions. Furthermore, using a combination of chemical and biophysical methods, we identify phosphatidylserine as a molecular target of Apo-15. We demonstrate that Apo-15 can be used for the quantification and imaging of drug-induced apoptosis in preclinical mouse models, thus creating opportunities for assessing the in vivo efficacy of anti-inflammatory and anti-cancer therapeutics. Programmed cell death or apoptosis is an essential biological process that is impaired in some diseases and can be used to assess the effectiveness of drugs. Here the authors design Apo-15 as a fluorogenic peptide for the detection and real-time imaging of apoptotic cells., N.D.B. acknowledges funding from OPTIMA (EP/L016559/1). R.S.F. acknowledges an MSCA Individual Fellowship (659046). L.M.T. acknowledges the support of Fundacion Antonio Martin Escudero (FAME) in the form of a post-doctoral fellowship. S.T.H. is an Australian Research Council Future Fellow (FT150100398). R.L. acknowledges funding from MINECO (CTQ2015-67870-P and ERA NET PCIN-2015-224). F.M.G. acknowledges financial help from the Spanish Ministry of Economy (FEDER MINECO PGC2018-099857-B-I00) and the Basque Government (IT264-19). M.E. acknowledges funding from Cold Spring Harbor Laboratory Cancer Center (P30-CA045508), Northwell Health, and the Thompson Family Foundation. M.V. acknowledges funding from an ERC Consolidator Grant (771443), the Biotechnology and Biological Sciences Research Council (BB/M025160/1), and The Royal Society (RG160289). The authors thank the technical support from the QMRI Flow Cytometry and Confocal Advanced Light Microscopy facilities at the University of Edinburgh and Yaiza Varela (UPV), Luxembourg Bio Technologies Ltd. (Rehovot) for the kind supply of reagents for peptide synthesis, and Astex Therapeutics, who kindly provided AT7519 as a gift. The authors also thank Prof. Chris Gregory (University of Edinburgh) for provision of BL-2 cells and valuable discussions.
Addi. Archivo Digital para la Docencia y la Investigación
Publicación Artículo científico (JournalArticle)

Towards a more precise therapy in cancer: Exploring epigenetic complexity

  • Cossío Mora, Fernando Pedro
  • Esteller, Manel
  • Berdasco, María
A plethora of preclinical evidences suggests that pharmacological targeting of epigenetic dysregulation is a potent strategy to combat human diseases. Nevertheless, the implementation of epidrugs in clinical practice is very scarce and mainly limited to haematological malignancies. In this review, we discuss cutting-edge strategies to foster the chemical design, the biological rationale and the clinical trial development of epidrugs. Specifically, we focus on the development of dual hybrids to exploit multitargeting of key epigenetic molecules deregulated in cancer; the study of epigenetic-synthetic lethality interactions as a mechanism to address loss-of-function mutations, and the combination of epidrugs with other therapies such as immunotherapy to avoid acquired chemoresistance and increase therapy sensitivity. By exploring these challenges, among others, the field of epigenetic chemical biology will increase its potential for clinical benefit, and more effective strategies targeting the aberrant epigenome in cancer are likely to be developed both in haematological and solid tumours., The authors thank CERCA Programme/Generalitat de Catalunya for institutional support. Research at M.B. lab is supported by Instituto de Salud Carlos III cofunded by European Regional Development Funds (ERDF/FEDER) a way to build Europe (PI15/00638 and PI18/00910). Research at F.P.C lab is supported by Spanish Ministerio de Ciencia e Innovacion and FEDER (CTQ2016-80375-P and CTQ2014-51912-REDC), by Gobierno Vasco/Eusko Jaurlaritza (IT-324-07) and by 2020 Framework Programme of the European Union (Euro-Cholangio-Net CA18122).
Dipòsit Digital de la UB
Publicación Artículo científico (JournalArticle)

A fluorogenic probe for granzyme B enables in-biopsy evaluation and screening of response to anticancer immunotherapies

  • Scott, Jamie I.
  • Mendive Tapia, Lorena
  • Gordon, Doireann
  • Barth, Nicole D.
  • Thompson, Emily J.
  • Cheng, Zhiming
  • Taggart, David
  • Kitamura, Takanori
  • Bravo-Blas, Alberto
  • Roberts, Edward W.
  • Juárez Jiménez, Jordi
  • Michel, Julien
  • Piet, Berber
  • Vries, I. Jolanda de
  • Verdoes, Martijn
  • Dawson, John
  • Carragher, Neil
  • O' Connor, Richard A.
  • Akram, Ahsan R.
  • Frame, Margaret
  • Serrels, Alan
  • Vendrell, Marc
Immunotherapy promotes the attack of cancer cells by the immune system; however, it is difficult to detect early responses before changes in tumor size occur. Here, we report the rational design of a fluorogenic peptide able to detect picomolar concentrations of active granzyme B as a biomarker of immune-mediated anticancer action. Through a series of chemical iterations and molecular dynamics simulations, we synthesize a library of FRET peptides and identify probe H5 with an optimal fit into granzyme B. We demonstrate that probe H5 enables the real-time detection of T cell-mediated anticancer activity in mouse tumors and in tumors from lung cancer patients. Furthermore, we show image-based phenotypic screens, which reveal that the AKT kinase inhibitor AZD5363 shows immune-mediated anticancer activity. The reactivity of probe H5 may enable the monitoring of early responses to anticancer treatments using tissue biopsies.
Dipòsit Digital de la UB
Publicación Artículo científico (JournalArticle)

A multicomponent reaction platform towards multimodal near-infrared BODIPY dyes for STED and fluorescence lifetime imaging

  • Fernandez, Antonio
  • Kielland, Nicola
  • Makda, Ashraff
  • Carragher, Neil
  • González-García, M. Carmen
  • Espinar-Barranco, Laura
  • González-Vera, Juan Antonio
  • Orte, Ángel
  • Lavilla Grífols, Rodolfo
  • Vendrell, Marc
We report a platform combining multicomponent reaction synthesis and automated cell-based screening to develop biocompatible NIR-BODIPY fluorophores. From a library of over 60 fluorophores, we optimised compound NIRBD-62c as a multimodal probe with suitable properties for STED super-resolution and fluorescence lifetime imaging. Furthermore, we employed NIRBD-62c for imaging trafficking inside cells and to examine how pharmacological inhibitors can alter the vesicular traffic between intracellular compartments and the plasma membrane.
Dipòsit Digital de la UB
Publicación Artículo científico (JournalArticle)

A fluorogenic cyclic peptide for imaging and quantification of drug-induced apoptosis

  • Barth, Nicole D.
  • Subirós Funosas, Ramon
  • Mendive Tapia, Lorena
  • Duffin, Rodger
  • Shields, Mario A.
  • Cartwright, Jennifer A.
  • Troeira Henriques, Sónia
  • Sot, Jesus
  • Goñi, Felix M.
  • Lavilla Grífols, Rodolfo
  • Marwick, John A.
  • Vermeren, Sonja
  • Rossi, Adriano G.
  • Egeblad, Mikala
  • Dransfield, Ian
  • Vendrell, Marc
Programmed cell death or apoptosis is a central biological process that is dysregulated in many diseases, including inflammatory conditions and cancer. The detection and quantification of apoptotic cells in vivo is hampered by the need for fixatives or washing steps for non-fluorogenic reagents, and by the low levels of free calcium in diseased tissues that restrict the use of annexins. In this manuscript, we report the rational design of a highly stable fluorogenic peptide (termed Apo-15) that selectively stains apoptotic cells in vitro and in vivo in a calcium-independent manner and under wash-free conditions. Furthermore, using a combination of chemical and biophysical methods, we identify phosphatidylserine as a molecular target of Apo-15. We demonstrate that Apo-15 can be used for the quantification and imaging of drug-induced apoptosis in preclinical mouse models, thus creating opportunities for assessing the in vivo efficacy of anti-inflammatory and anti-cancer therapeutics.
Dipòsit Digital de la UB
Publicación Artículo científico (JournalArticle)

Fluorogenic Trp(redBODIPY) cyclopeptide targeting keratin 1 for imaging of aggressive carcinomas

  • Subirós Funosas, Ramon
  • Cheuk Lam Ho, Vivian
  • Barth, Nicole D.
  • Mendive Tapia, Lorena
  • Pappalardo, Morena
  • Barril Alonso, Xavier
  • Ma, Ruoyu
  • Zhang, Cheng-Bin
  • Qian, Bin-Zhi
  • Sintes Marcos, Miquel
  • Ghashghaei, Ouldouz
  • Lavilla Grífols, Rodolfo
  • Vendrell, Marc
Keratin 1 (KRT1) is overexpressed in squamous carcinomas and associated with aggressive pathologies in breast cancer. Herein we report the design and preparation of the first Trp-based red fluorogenic amino acid, which is synthetically accessible in a few steps and displays excellent photophysical properties, and its application in a minimally-disruptive labelling strategy to prepare a new fluorogenic cyclopeptide for imaging of KRT1+ cells in whole intact tumour tissues.
Dipòsit Digital de la UB
Publicación Artículo científico (JournalArticle)

SCOTfluors: Small, Conjugatable, Orthogonal, and Tunable Fluorophores for In Vivo Imaging of Cell Metabolism

  • Benson, Sam
  • Fernandez, Antonio
  • Barth, Nicole D.
  • de Moliner, Fabio
  • Horrocks, Mathew H.
  • Herrington, C. Simon
  • Abad, José Luis
  • Delgado Cirilo, Antonio
  • Kelly, Lisa
  • Chang, Ziyuan
  • Feng, Yi
  • Nishiure, Miyako
  • Hori, Yuichiro
  • Kikuchi, Kazuya
  • Vendrell, Marc
The transport and trafficking of metabolites are critical for the correct functioning of live cells. However, in situ metabolic imaging studies are hampered by the lack of fluorescent chemical structures that allow direct monitoring of small metabolites under physiological conditions with high spatial and temporal resolution. Herein, we describe SCOTfluors as novel small‐sized multi‐colored fluorophores for real‐time tracking of essential metabolites in live cells and in vivo and for the acquisition of metabolic profiles from human cancer cells of variable origin.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

SCOTfluors: Small, Conjugatable, Orthogonal, and Tunable Fluorophores for In Vivo Imaging of Cell Metabolism

  • Benson, Sam
  • Fernández, Antonio
  • Barth, Nicole D.
  • de Moliner, Fabio
  • Horrocks, Mathew H.
  • Herrington, Simon
  • Abad, José Luis
  • Delgado Huertas, Antonio
  • Kelly, Lisa
  • Chang, Ziyuan
  • Feng, Yi
  • Nishiura, Miyako
  • Hori, Yuichiro
  • Kikuchi, Kazuya
  • Vendrell, Marc
The transport and trafficking of metabolites are critical for the correct functioning of live cells. However, in situ metabolic imaging studies are hampered by the lack of fluorescent chemical structures that allow direct monitoring of small metabolites under physiological conditions with high spatial and temporal resolution. Herein, we describe SCOTfluors as novel small-sized multi-colored fluorophores for real-time tracking of essential metabolites in live cells and in vivo and for the acquisition of metabolic profiles from human cancer cells of variable origin. © 2019 The Authors. Published by Wiley-VCH Verlag GmbH & Co. KGaA., The authors acknowledge funding from Medical Research Scotland (S.B.: 879-2015), MSCA Individual Fellowship (A.F.: 704912), OPTIMA (N.D.B.: EP/L016559/1), Wellcome Trust Sir Henry Dale Fellowship (Y.F.: 100104/Z/12/Z) and the Spanish Ministry of Science, Innovation and Universities (J.L.A, A.D.: CTQ2017-85378-R). M.V. acknowledges funds from ERC Consolidator Grant (771443), Biotechnology and Biological Sciences Research Council (BB/M025160/1) and the Royal Society (IEC\R3\170132). The authors thank the technical support from the Flow Cytometry and the Confocal Advanced Light Microscopy units at the University of Edinburgh., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Fluorogenic Granzyme A substrates enable real-time imaging of adaptive immune cell activity

  • Cheng, Zhiming
  • Thompson, Emily J.
  • Mendive-Tapia, Lorena
  • Scott, Jamie I.
  • Benson, Sam
  • Kitamura, Takanori
  • Senán Salinas, Ana
  • Samarakoon, Youhani
  • Roberts, Edward W.
  • Arias, Maykel
  • Pardo, Julián
  • Gálvez Buerba, Eva Mª
6 figures., Cytotoxic immune cells, including T lymphocytes (CTLs) and natural killer (NK) cells, are essential components of the host response against tumors. CTLs and NK cells secrete granzyme A (GzmA) upon recognition of cancer cells; however, there are very few tools that can detect physiological levels of active GzmA with high spatiotemporal resolution. Herein, we report the rational design of the near-infrared fluorogenic substrates for human GzmA and mouse GzmA. These activity-based probes display very high catalytic efficiency and selectivity over other granzymes, as shown in tissue lysates from wild-type and GzmA knock-out mice. Furthermore, we demonstrate that the probes can image how adaptive immune cells respond to antigen-driven recognition of cancer cells in real time., A. S. acknowledges a PhD fellowship from the Aragon Government. M. A. A. acknowledges funds from the Ministry of Economy and Competitiveness, Spain (IJC2019- 039192-I). This research was supported by CIBER (CB 2021), Instituto de Salud Carlos III, Ministerio de Ciencia e Innovación and Unión Europea-NextGenerationEU, FEDER (Group B29_20R), Ministry of Science, Innovation and Universities and Agencia Estatal de Investigación, Spain (SAF2017-83120-C2-1-R and PID2020-113963RB-I00). T. K. acknowledges funding from an MRC Career Development Award (MR/S006982/1) and an MRC Centre Grant (MR/N022556/1). E. W. R. acknowledges a Cancer Research UK grant (A_BICR_1920_Roberts). M. V. acknowledges funds from an ERC Consolidator Grant (DYNAFLUORS, 771443) and an ERC PoC Grant (IBDIMAGE, 957535). This project has received funding from the European Union's Horizon 2020 research and innovation program under the Marie Sklodowska-Curie grant agreement (859908)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

A fluorogenic cyclic peptide for imaging and quantification of drug-induced apoptosis

  • Barth, Nicole D.
  • Subiros-Funosas, Ramón
  • Mendive-Tapia, Lorena
  • Duffin, Rodger
  • Shields, Mario A.
  • Cartwright, Jennifer A.
  • Henriques, Sónia Troeira
  • Sot, Jesús
  • Goñi, Félix M.
  • Lavilla, Rodolfo
  • Marwick, John A.
  • Vermeren, Sonja
  • Rossi, Adriano G.
  • Egeblad, Mikala
  • Dransfield, Ian
  • Vendrell, Marc
Programmed cell death or apoptosis is a central biological process that is dysregulated in many diseases, including inflammatory conditions and cancer. The detection and quantification of apoptotic cells in vivo is hampered by the need for fixatives or washing steps for non-fluorogenic reagents, and by the low levels of free calcium in diseased tissues that restrict the use of annexins. In this manuscript, we report the rational design of a highly stable fluorogenic peptide (termed Apo-15) that selectively stains apoptotic cells in vitro and in vivo in a calcium-independent manner and under wash-free conditions. Furthermore, using a combination of chemical and biophysical methods, we identify phosphatidylserine as a molecular target of Apo-15. We demonstrate that Apo-15 can be used for the quantification and imaging of drug-induced apoptosis in preclinical mouse models, thus creating opportunities for assessing the in vivo efficacy of anti-inflammatory and anti-cancer therapeutics., N.D.B. acknowledges funding from OPTIMA (EP/L016559/1). R.S.F. acknowledges an MSCA Individual Fellowship (659046). L.M.T. acknowledges the support of Fundacion Antonio Martin Escudero (FAME) in the form of a post-doctoral fellowship. S.T.H. is an Australian Research Council Future Fellow (FT150100398). R.L. acknowledges funding from MINECO (CTQ2015-67870-P and ERA NET PCIN-2015-224). F.M.G. acknowledges financial help from the Spanish Ministry of Economy (FEDER MINECO PGC2018-099857-B-I00) and the Basque Government (IT264-19). M.E. acknowledges funding from Cold Spring Harbor Laboratory Cancer Center (P30-CA045508), Northwell Health, and the Thompson Family Foundation. M.V. acknowledges funding from an ERC Consolidator Grant (771443), the Biotechnology and Biological Sciences Research Council (BB/M025160/1), and The Royal Society (RG160289)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Selective detection of active extracellular granzyme A by using a novel fluorescent immunoprobe with application to inflammatory diseases

  • Senán Salinas, Ana
  • Comas, Laura
  • Esteban, Patricia
  • Garzón, Marcela
  • Cheng, Zhiming
  • Santiago, Llipsy
  • Domingo, María Pilar
  • Ramírez-Labrada, Ariel
  • Paño, José Ramón
  • Vendrell, Marc
  • Pardo, Julián
  • Arias, Maykel
  • Gálvez Buerba, Eva Mª
8 figures.-- Supplementary information available., Granzymes (Gzms), a family of serine proteases, expressed by immune and nonimmune cells, present perforin-dependent and independent intracellular and extracellular functions. When released in the extracellular space, GzmA, with trypsin-like activity, is involved in the pathophysiology of different inflammatory diseases. However, there are no validated specific systems to detect active forms of extracellular GzmA, making it difficult to assess its biological relevance and potential use as a biomarker. Here, we have developed fluorescence-energy resonance-transfer (FRET)-based peptide probes (FAM-peptide-DABCYL) to specifically detect GzmA activity in tissue samples and biological fluids in both mouse and human samples during inflammatory diseases. An initial probe was developed and incubated with GzmA and different proteases like GzmB and others with similar cleavage specificity as GzmA like GzmK, thrombin, trypsin, kallikrein, or plasmin. After measuring fluorescence, the probe showed very good specificity and sensitivity for human and mouse GzmA when compared to GzmB, its closest homologue GzmK, and with thrombin. The specificity of this probe was further refined by incubating the samples in a coated plate with a GzmA-specific antibody before adding the probe. The results show a high specific detection of soluble GzmA even when compared with other soluble proteases with very similar cleavage specificity like thrombin, GzmK, trypsin, kallikrein, or plasmin, which shows nearly no fluorescence signal. The high specific detection of GzmA was validated, showing that using pure proteins and serum and tissue samples from GzmA-deficient mice presented a significant reduction in the signal compared with WT mice. The utility of this system in humans was confirmed, showing that GzmA activity was significantly higher in serum samples from septic patients in comparison with healthy donors. Our results present a new immunoprobe with utility to detect extracellular GzmA activity in different biological fluids, confirming the presence of active forms of the soluble protease in vivo during inflammatory and infectious diseases., This research was supported by CIBER─Consorcio Centro de Investigación Biomédica en Red─CIBERINFEC (CB21-13-0087), Instituto de Salud Carlos III, Ministerio de Ciencia e Innovación and Unión Europea─NextGenerationEU, FEDER (Fondo Europeo de Desarrollo Regional), Gobierno de Aragón (Group B29_23R and LMP139_21), Ministerio de Ciencia, Innovación e Universidades (MCNU), Agencia Estatal de Investigación (PID2020-113963RB-I00, SAF2017-83120-C2-1-R). A.S.-S. was supported by a PhD fellowship from the Aragon Government. M.A. acknowledges funds from the Ministry of Economy and Competitiveness, Spain (FJCI-2017-31629, IJC2019-039192-I). M.V. acknowledges funds from an ERC Consolidator Grant (DYNAFLUORS, 771443), and this project has received funding from the European Union’s Horizon 2020 research and innovation program under the Marie Sklodowska-Curie grant agreement (859908)., Peer reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

A multicomponent reaction platform towards multimodal near-infrared BODIPY dyes for STED and fluorescence lifetime imaging

  • Fernandez, Antonio
  • Kielland, Nicola
  • Makda, Ashraff
  • Carragher, Neil
  • González-García, M. Carmen
  • Espinar-Barranco, Laura
  • González-Vera, Juan Antonio
  • Orte, Ángel
  • Lavilla Grífols, Rodolfo
  • Vendrell, Marc
We report a platform combining multicomponent reaction synthesis and automated cell-based screening to develop biocompatible NIR-BODIPY fluorophores. From a library of over 60 fluorophores, we optimised compound NIRBD-62c as a multimodal probe with suitable properties for STED super-resolution and fluorescence lifetime imaging. Furthermore, we employed NIRBD-62c for imaging trafficking inside cells and to examine how pharmacological inhibitors can alter the vesicular traffic between intracellular compartments and the plasma membrane.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Fluorogenic Trp(redBODIPY) cyclopeptide targeting keratin 1 for imaging of aggressive carcinomas

  • Subirós Funosas, Ramon
  • Cheuk Lam Ho, Vivian
  • Barth, Nicole D.
  • Mendive Tapia, Lorena
  • Pappalardo, Morena
  • Barril Alonso, Xavier
  • Ma, Ruoyu
  • Zhang, Cheng-Bin
  • Qian, Bin-Zhi
  • Sintes Marcos, Miquel
  • Ghashghaei, Ouldouz
  • Lavilla Grífols, Rodolfo
  • Vendrell, Marc
Keratin 1 (KRT1) is overexpressed in squamous carcinomas and associated with aggressive pathologies in breast cancer. Herein we report the design and preparation of the first Trp-based red fluorogenic amino acid, which is synthetically accessible in a few steps and displays excellent photophysical properties, and its application in a minimally-disruptive labelling strategy to prepare a new fluorogenic cyclopeptide for imaging of KRT1+ cells in whole intact tumour tissues.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

A fluorogenic cyclic peptide for imaging and quantification of drug-induced apoptosis

  • Barth, Nicole D.
  • Subirós Funosas, Ramon
  • Mendive Tapia, Lorena
  • Duffin, Rodger
  • Shields, Mario A.
  • Cartwright, Jennifer A.
  • Troeira Henriques, Sónia
  • Sot, Jesus
  • Goñi, Felix M.
  • Lavilla Grífols, Rodolfo
  • Marwick, John A.
  • Vermeren, Sonja
  • Rossi, Adriano G.
  • Egeblad, Mikala
  • Dransfield, Ian
  • Vendrell, Marc
Programmed cell death or apoptosis is a central biological process that is dysregulated in many diseases, including inflammatory conditions and cancer. The detection and quantification of apoptotic cells in vivo is hampered by the need for fixatives or washing steps for non-fluorogenic reagents, and by the low levels of free calcium in diseased tissues that restrict the use of annexins. In this manuscript, we report the rational design of a highly stable fluorogenic peptide (termed Apo-15) that selectively stains apoptotic cells in vitro and in vivo in a calcium-independent manner and under wash-free conditions. Furthermore, using a combination of chemical and biophysical methods, we identify phosphatidylserine as a molecular target of Apo-15. We demonstrate that Apo-15 can be used for the quantification and imaging of drug-induced apoptosis in preclinical mouse models, thus creating opportunities for assessing the in vivo efficacy of anti-inflammatory and anti-cancer therapeutics.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

A fluorogenic probe for granzyme B enables in-biopsy evaluation and screening of response to anticancer immunotherapies

  • Scott, Jamie I.
  • Mendive Tapia, Lorena
  • Gordon, Doireann
  • Barth, Nicole D.
  • Thompson, Emily J.
  • Cheng, Zhiming
  • Taggart, David
  • Kitamura, Takanori
  • Bravo-Blas, Alberto
  • Roberts, Edward W.
  • Juárez Jiménez, Jordi
  • Michel, Julien
  • Piet, Berber
  • Vries, I. Jolanda de
  • Verdoes, Martijn
  • Dawson, John
  • Carragher, Neil
  • O' Connor, Richard A.
  • Akram, Ahsan R.
  • Frame, Margaret
  • Serrels, Alan
  • Vendrell, Marc
Immunotherapy promotes the attack of cancer cells by the immune system; however, it is difficult to detect early responses before changes in tumor size occur. Here, we report the rational design of a fluorogenic peptide able to detect picomolar concentrations of active granzyme B as a biomarker of immune-mediated anticancer action. Through a series of chemical iterations and molecular dynamics simulations, we synthesize a library of FRET peptides and identify probe H5 with an optimal fit into granzyme B. We demonstrate that probe H5 enables the real-time detection of T cell-mediated anticancer activity in mouse tumors and in tumors from lung cancer patients. Furthermore, we show image-based phenotypic screens, which reveal that the AKT kinase inhibitor AZD5363 shows immune-mediated anticancer activity. The reactivity of probe H5 may enable the monitoring of early responses to anticancer treatments using tissue biopsies.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

SCOTfluors: Small, Conjugatable, Orthogonal, and Tunable Fluorophores for In Vivo Imaging of Cell Metabolism

  • Benson, Sam
  • Fernandez, Antonio
  • Barth, Nicole D.
  • de Moliner, Fabio
  • Horrocks, Mathew H.
  • Herrington, C. Simon
  • Abad, José Luis
  • Delgado Cirilo, Antonio
  • Kelly, Lisa
  • Chang, Ziyuan
  • Feng, Yi
  • Nishiure, Miyako
  • Hori, Yuichiro
  • Kikuchi, Kazuya
  • Vendrell, Marc
The transport and trafficking of metabolites are critical for the correct functioning of live cells. However, in situ metabolic imaging studies are hampered by the lack of fluorescent chemical structures that allow direct monitoring of small metabolites under physiological conditions with high spatial and temporal resolution. Herein, we describe SCOTfluors as novel small‐sized multi‐colored fluorophores for real‐time tracking of essential metabolites in live cells and in vivo and for the acquisition of metabolic profiles from human cancer cells of variable origin.